Modulation of glycolytic ATP production
Patent 5707971 Issued on January 13, 1998. Estimated Expiration Date: 
June 7, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 7, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesUse of fructose-1,6-diphosphate for treating myocardial infarction Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP) Method of preserving blood Use of fructose-1,6-diphosphate for treating myocardial infarction Use of pyruvate to prevent neuronal degeneration associated with ischemia Patent #: 5395822 InventorAssigneeApplicationNo. 476035 filed on 06/07/1995US Classes:514/43, Nitrogen containing hetero ring514/45, Purines (including hydrogenated) (e.g., adenine, guanine, etc.)514/694FormaldehydeExaminersPrimary: Rollins, John W.Attorney, Agent or FirmInternational ClassesA61K 031/70A61K 031/115 AbstractDelivery of fuel and cofactors augments ATP production in cells, and mitigates damages in ischemic or metabolically impaired tissues. The processes may be particularly effective in acute or chronic ischemic conditions, for reversing anesthesia, for treating diabetes, for producing or preventing coma due to lack of fuel or ATP, for reversing processes of aging, as dietary supplements, as performance enhancers, for example, in sports, for tissue transplantation and other surgery, and for cold storage or cryopreservation of tissues such as organs.Other References
| |
